华润医药附属华润双鹤获准发行总额为30亿元的公司债券

Core Viewpoint - China Resources Pharmaceutical (03320) announced that its non-wholly owned subsidiary, China Resources Double Crane Pharmaceutical Co., Ltd. (600062), has received approval from the China Securities Regulatory Commission for the issuance of corporate bonds to qualified investors in the People's Republic of China [1] Group 1 - The approval notice (Zheng Jian Xu Ke [2026] No. 118) is valid for 24 months from the date of issuance [1] - Within the validity period, China Resources Double Crane can issue corporate bonds totaling RMB 3 billion [1]